89. リンパ脈管筋腫症
[臨床試験数:38,薬物数:42(DrugBank:19),標的遺伝子数:26,標的パスウェイ数:134

Searched query = "Lymphangioleiomyomatosis", "LAM"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03131999
(ClinicalTrials.gov)
January 23, 201824/4/2017LAM Pilot Study With Imatinib MesylateLAM Pilot Study With Imatinib MesylateLymphangioleiomyomatosisDrug: Imatinib Mesylate 400Mg Capsule;Drug: Placebo - CapsuleMedical University of South CarolinaColumbia UniversityCompleted18 YearsN/AAll18Phase 1/Phase 2United States